Pharming Group N.V. Comprehensive Income
Pharming Group N.V. (PHAR) reported Comprehensive Income of $31.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncome · last filed 2026-04-02
EUR
| Period end | Comprehensive Income 12 month |
|---|---|
| 2020-12-31 | 33.02M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 36.16M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 25.34M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Comprehensive Income 12 month |
|---|---|
| 2025-12-31 | $31.60M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$23.74M 20-F · filed 2026-04-02 |
| 2023-12-31 | -$3.44M 20-F · filed 2026-04-02 |
| 2022-12-31 | $2.62M 20-F · filed 2025-04-03 |
| 2021-12-31 | -$1.09M 20-F · filed 2024-04-04 |
| 2020-12-31 | $52.70M 20-F · filed 2023-04-05 |
| 2019-12-31 | $45.70M 20-F · filed 2022-04-06 |